​Beginning April 13, 2020, APHL has conducted a weekly survey of up to 100 state, local and territorial public health laboratories (PHLs) to collect the status of current and projected capability and capacity of laboratories to test for SARS-CoV-2, the virus that causes the Coronavirus Disease (COVID-19). Data from this survey is used to inform HHS, FEMA, CDC and other federal partners to support public health laboratory supply and reagent needs. ​​

Below is a dashboard of high-level data from this survey, updated weekly with the previous week's data. PDF versions of the weekly reports are also available on the left side of the page.

Week of

Overall Testing Capacity

Current testing and supply demands (n=)


GearIcon

Number of specimens tested during the previous week (Data from CDC)

LineChartIcon

PHLs able to meet their current testing demand

GearIcon

PHLs that will run out of reagents or supplies within a week

Serology/Antibody Testing

Status of serological testing implementation (n=)

%

Currently Performing

%

Intend To

%

Not Planned Yet

High Throughput Testing Platforms

Status of high throughput testing platforms (n=)

%

Labs with at least one high throughput testing platform

%

Labs without high throughput testing platform

Number of high throughput platforms per laboratory, of those with at least one (n=)

EUA Molecular Tests

Changes in Number of EUA Molecular Test Types in Use per Laboratory (n=)

Most Common EUA Molecular Tests in Use (n=)

Test Description % of PHLs

Footnotes

* Data based on survey-long compilation

** Data updated monthly

High throughput platforms are automated equipment that can test many specimens at a time while minimizing the hands-on time required by laboratory staff. High throughput platforms currently in use are Hologic Panter, Hologic Panther Fusion, Abbott m200 and the BD Max.